4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001104659-20-094753
President and CEO acquired 447,927 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bashan Dror President and CEO | 2020-08-11 | Grant or award | +447,927 | 447,927 | I |
Loading xslF345X03/tm2027548d2_4.xml…